Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis
Clinical trial NCT03343639 · COMPLETED
Trial details
- NCT number
- NCT03343639
- Sponsor
- Vyne Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2018-10-23
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.